Christopher M. Jewell
Chief Scientific Officer · Cartesian Therapeutics, Inc.
- 2024
- Nov 21, 2024
- 2
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Christopher M. Jewell. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Timothy A. Springer - $14.15M in RNAC purchases and sales on record
- Metin Kurtoglu - $2.43M in RNAC purchases and sales on record
- Milos Miljkovic - $908K in RNAC purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher M. Jewell?
Christopher M. Jewell is a corporate insider, tracked as Chief Scientific Officer of Cartesian Therapeutics, Inc. (RNAC). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Christopher M. Jewell last file a Form 4?
The most recent primary Form 4 on record is dated 21 November 2024, one of 2 filings going back to 2024.
Has Christopher M. Jewell been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($875K) across all tracked filings.
